Diagnostic Imaging

Radiologists use diagnostic imaging to non-invasively look inside the body to help determine the causes of an injury or an illness, and confirm a diagnosis. Providers use many imaging modalities to do so, including CT, MRI, X-ray, Ultrasound, PET and more.

RSS icon

ACR: Stage 2 MU issued on aggressive timeline,' more to come

The American College of Radiology (ACR) said the Stage 2 meaningful use (MU) final rules were released publically on an unusually aggressive timeline, but will otherwise wait to issue a further analysis.

ACC webinar to cover coding basics

An upcoming American College of Cardiology (ACC) webinar, hosted by the ACCs Cardiovascular Administrator Work Group, will cover the coding essentials that cardiovascular professionals need to thrive.

Study: Canadian CT Head Rule bests N.O. Criteria for predictive value

In a comparison of clinical decision rules for use of CT in mild head injury, the Canadian CT Head Rule was better able to predict need for neurosurgical intervention than the New Orleans Criteria, according to a study published online Aug. 24 in Annals of Emergency Medicine.

This week's top headlines: MU Stage 2, provider success stories

This weeks top stories offered both a look toward the future, with the publishing of the meaningful use Stage 2 final rule, and also a look back at the outcomes of initiatives promoting evidence-based practice in Washington State and dose reduction at the Mayo Clinic.

It's time for an anticoagulant faceoff

By now the message is clear: We need a large, randomized clinical trial that allows a head-to-head comparison of novel oral anticoagulants before physicians can with confidence take atrial fibrillation patients off warfarin. So whats the holdup?

Updated Xience nets CE Mark, with shorter DAPT time

The Xience Xpedition Everolimus Eluting Coronary Stent System (Abbott) has received CE Mark in Europe for the treatment of coronary artery disease. The stent has indications to treat patients with complex disease such as diabetes, as well as an indication for a minimum duration of three months of dual anti-platelet therapy (DAPT).

Even with targeted programs, gender differences with diabetes care remain

There are major gender differences in healthcare utilization of type 2 diabetes patients in Germany despite a high rate of participation in disease management programs to treat diabetes mellitus in this region, according to a cohort study in the July issue of the American Journal of Managed Care.

FDA allows for generic version of Actos

The FDA approved the first generic version of Actos (pioglitazone hydrochloride) tablets on Aug. 17 to improve blood glucose control in adults with type 2 diabetes. This approval came in the same week that Watson Pharmaceuticals sued the FDA for not approving the generic drug quickly enough.

Displaying 921 - 928 of 7499

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.